Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Three-dimensional spatial transcriptomics uncovers cell type localizations in the human rheumatoid arthritis synovium

Three-dimensional spatial transcriptomics uncovers cell type localizations in the human rheumatoid arthritis synovium

Thumbnail Image
Download
Name

s42003-022-03050-3.pdf

Description
Published version
Size

4.93 MB

Format

Adobe PDF

Checksum (MD5)

a5b473e98fc6d4f702439c9c960b29b5

sword-2023-01-13T15:35:14.original.xml (130 B)
Original SWORD entry document
Author(s)
Vickovic, Sanja
•
Schapiro, Denis
•
Carlberg, Konstantin
•
Lötstedt, Britta
•
Larsson, Ludvig
•
Hildebrandt, Franziska
•
Korotkova, Marina
•
Hensvold, Aase H
•
Catrina, Anca I
•
Sorger, Peter K
more
Date Issued
2022
Journal
Communications Biology
Publisher
Springer Science and Business Media LLC
Citation
Vickovic, Sanja, Schapiro, Denis, Carlberg, Konstantin, Lötstedt, Britta, Larsson, Ludvig et al. 2022. "Three-dimensional spatial transcriptomics uncovers cell type localizations in the human rheumatoid arthritis synovium." Communications Biology, 5 (1).
Version
Final published version
Abstract
AbstractThe inflamed rheumatic joint is a highly heterogeneous and complex tissue with dynamic recruitment and expansion of multiple cell types that interact in multifaceted ways within a localized area. Rheumatoid arthritis synovium has primarily been studied either by immunostaining or by molecular profiling after tissue homogenization. Here, we use Spatial Transcriptomics, where tissue-resident RNA is spatially labeled in situ with barcodes in a transcriptome-wide fashion, to study local tissue interactions at the site of chronic synovial inflammation. We report comprehensive spatial RNA-Seq data coupled to cell type-specific localization patterns at and around organized structures of infiltrating leukocyte cells in the synovium. Combining morphological features and high-throughput spatially resolved transcriptomics may be able to provide higher statistical power and more insights into monitoring disease severity and treatment-specific responses in seropositive and seronegative rheumatoid arthritis.
MIT Department
Massachusetts Institute of Technology. Department of Biology
Terms of Use
Creative Commons Attribution 4.0 International license
https://creativecommons.org/licenses/by/4.0/
Persistent DSpace Link
https://hdl.handle.net/1721.1/147101
DOI of Published Version
https://doi.org/10.1038/S42003-022-03050-3
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.